In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis.
Kidd SG, Bogaard M, Carm KT, Bakken AC, Maltau AMV, Løvf M, Lothe RA, Axcrona K, Axcrona U, Skotheim RI. Mol Oncol. 2022 Aug; 16(15):2810-2822. Epub 2022 Jun 18.